Gelonghui May 26| CITIC Construction Investment pointed out that at the 2024 ASCO conference, many domestic innovative pharmaceutical companies released the latest research results of their clinical trials. Overall, China's innovative pharmaceutical companiesbestp2ecryptogames2022The forms of oncology drugs include monoclonal antibodies, dual antibodies and ADCs. The product design is innovative and the clinical trial results are equally excellent, demonstrating well in various oncology treatments.bestp2ecryptogames2022clinical effect. We believe that China's innovative pharmaceutical companies continue to make efforts on the oncology track, and many products have demonstrated the potential of BIC in oncology indications. More subsequent clinical results are worthy of attention.